A new breed of direct-to-consumer services is aggressively using targeted ads to sell habit-forming medications. In short, AI and surveillance capitalism, which empower today's targeted ads, have joined forces with the deadly OxyContin playbook. As the Journal reported, after ADHD medications grew to 20% of the VC-funded company's business, driving a $4.8 billion valuation, things came crashing to earth. We as a society may have come to accept being stalked by targeted ads, but consequences are much graver when the product itself is a danger. But above all, we need rules that ban targeted ads for drugs that can get patients hooked.

---

Persons: Taylor Swift, they're, haven't, Van Zee, OxyContin, prescribers, Dr, David Sack, Anthony Yeung, recreationally, Yann Poncin, shih, Ryan Haight, Ryan Haight Act's, Albert Fox Cahn Organizations: Circle, Purdue, American, of Public Health, Sackler family's pharma, Physicians, Yale School of Medicine, Bloomberg, Drug Enforcement Agency, Department of Health, Human Services, Ryan, Twitter, FDA Locations: Canadian, California, United States, New Zealand, New York